Gharib Tarek, Mohey Ahmed, Fathi Abdallah, Alhefnawy Mohamed, Alazaby Hisham, Eldakhakhny Amr
Urol Int. 2018;101(2):161-166. doi: 10.1159/000490623. Epub 2018 Jul 19.
To compare the efficacy and safety of silodosin against tamsulosin as medical expulsion therapeutic agent in stone lower 1/3rd ureter.
One hundred fifty patients divided equally into 2 groups I and II received silodosin 8 mg and tamsulosin 0.4 mg respectively. Patients aged 18 years or older having single unilateral stone 10 mm or less were included in the study. Patients with bilateral or multiple stones, marked hydronephrosis, previous open or endoscopic surgery and having urinary infection were excluded. Patients were followed weekly for 4 weeks by ultrasonography, plain radiography of the urinary tract and CT of the urinary tract when indicated.
Silodosin showed better results against tamsulosin as stone expulsion rate in silodosin and tamsulosin groups was 82.4 and 61.5% respectively with significant difference (p = 0.007). Also, the stone expulsion time was significantly lower in silodosin against tamsulosin groups as it was 9.4 ± 3.8 vs. 12.7 ± 5.1 days in group I and II respectively (p = 0.001). The adverse effects were comparable with non-significant more retrograde ejaculation in the silodosin group.
Silodosin showed better efficacy in the stone expulsion rate and time with comparable safety of both drugs, with nonsignificant more retrograde ejaculation in silodosin.
比较西洛多辛与坦索罗辛作为药物排石治疗剂在输尿管下段结石治疗中的疗效和安全性。
150例患者平均分为两组,分别给予西洛多辛8mg和坦索罗辛0.4mg。纳入研究的患者年龄在18岁及以上,患有单个单侧结石且直径为10mm或更小。排除双侧或多发结石、明显肾积水、既往有开放手术或内镜手术史以及有泌尿系统感染的患者。必要时,每周对患者进行超声检查、泌尿系统平片和泌尿系统CT检查,持续4周。
西洛多辛在排石方面比坦索罗辛效果更好,西洛多辛组和坦索罗辛组的排石率分别为82.4%和61.5%,差异有统计学意义(p = 0.007)。此外,西洛多辛组的排石时间明显短于坦索罗辛组第一组和第二组分别为9.4±3.8天和12.7±5.1天(p = 0.001)。不良反应相当,西洛多辛组逆行射精发生率略高,但无统计学意义。
西洛多辛在排石率和排石时间方面疗效更好,两种药物安全性相当,西洛多辛组逆行射精发生率略高,但无统计学意义。